UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 10, 2025
enGene Holdings Inc.
(Exact name of registrant as specified in its charter)
British Columbia |
|
001-41854
|
|
00-0000000
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
4868 Rue Levy, Suite 220
Saint-Laurent, Quebec
|
|
H4R 2P1
|
(Address of principal executive offices)
|
|
(Zip code)
|
Registrant's telephone number, including area code (514) 332-4888
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Shares
|
ENGN
|
NASDAQ
|
Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per Common Share
|
ENGNW
|
NASDAQ
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of this chapter):
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Approval of the enGene Holdings Inc. 2025 Employee Stock Purchase Plan
As described in Item 5.07 of this Current Report on Form 8-K, on June 10, 2025, at its 2025 Annual General Meeting of shareholders (the “Annual
Meeting”), the shareholders of enGene Holdings Inc. (the “Company”) approved the adoption of the 2025 Employee Stock Purchase Plan (the “ESPP”), pursuant to which 2,000,000 common shares of the Company, no par value (the “Common Shares”), will be reserved for issuance.
The ESPP is intended to promote the interests of the Company by providing eligible employees with the opportunity to acquire a proprietary interest in
the Company through participation in an employee stock purchase plan designed to qualify under Section 423 of the Internal Revenue Code of 1986 (the “Code”) for one or more specified offerings made under the Plan, or where determined appropriate by
the Plan Administrator under Section 3(b), outside the requirements of Code Section 423. The number of Common Shares reserved for issuance under the ESPP will be limited to 2,000,000 shares. The shares issuable under the ESPP will be made available
from authorized but unissued common shares. Shares that are cancelled, terminated, forfeited, fail to vest, or for any other reason are not paid or delivered under the ESPP will generally be available for subsequent offering periods under the ESPP.
The Plan is effective as of June 10, 2025, which was the date of the Annual Meeting.
For a further description of the terms and conditions of the ESPP, as approved by shareholders, see “Proposal 2: Approval of the 2025 Employee Stock
Purchase Plan Proposal” in the Company’s definitive Proxy Statement, as filed with the Securities and Exchange Commission on May 9, 2025 (the “Proxy Statement”), which description is incorporated herein by reference.
The foregoing description of the ESPP, including the description contained in the Proxy Statement, is qualified in its entirety by reference to the full
text of the ESPP, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
The Annual Meeting of the Company was held on June 10, 2025 at 8:30 a.m. EDT. A total of 38,101,263 of the Company’s Common Shares were present or
represented by proxy at the Annual Meeting, representing approximately 74.60% of the Company’s 51,070,851 Common Shares that were outstanding and entitled to vote at the Annual Meeting as of the record date of April 29, 2025.
Set forth below, and pursuant to the requirements set out in subsection 11.3 of National Instrument 51-102, are the final voting results for each of the
matters submitted to a vote of the shareholders at the Annual Meeting, which matters are each described in further detail in the Company’s Proxy Statement:
Proposal 1 – Election of Directors
|
|
|
|
|
|
|
Director Nominee
|
|
For
|
|
Withhold
|
|
Broker Non-Votes
|
Gerald Brunk
|
|
30,481,847
|
|
8,154
|
|
7,611,262
|
Dr. Richard Glickman
|
|
26,312,872
|
|
4,177,129
|
|
7,611,262
|
Proposal 2 – Approval of the enGene Holdings Inc. 2025 Employee Stock Purchase Plan
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
30,152,713
|
|
8,427
|
|
328,861
|
|
7,611,262
|
Proposal 3 – Appointment and Remuneration of Auditor
For
|
|
Withhold
|
|
Broker Non-Votes
|
38,101,229
|
|
34
|
|
-
|
Item 9.01. Financial Statements and Exhibits.
|
|
|
Exhibit Number
|
|
Description
|
|
|
|
|
|
|
|
104
|
|
Cover Page Interactive Data File (Formatted as Inline XBRL)
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
ENGENE HOLDINGS INC.
|
|
|
Date: June 10, 2025
|
By:
|
/s/ Ronald H. W. Cooper
|
|
Name: Ronald H. W. Cooper
|
|
Title: Chief Executive Officer
|